Conocerse siempre ayuda
El Global
Les voy a pedir que esta semana acepten que me refiera al equipo de Faus & Moliner para ilustrar el mensaje que me gustaría trasladar. El martes pasado se hizo público que habíamos sido galardonados con el Premio Expansión como Mejor Despacho de Abogados en la categoría Ciencias de la Salud. Tras la lógica satisfacción... Read More
Strict interpretation of the “significant benefit” condition for the designation of an orphan medicinal product
Judgement of the General Court of 16 May 2019, Case T-733/17, GMP-Orphan v European Commission
Capsulas Nº 202
Background One of the available ways to obtain orphan drug designation for a medicinal product is to prove that such medicinal product will be of “significant benefit” to the patients. This “significant benefit” shall mean either (a) a clinically relevant advantage, or (b) a “major contribution” to patient care; and must be proved by means... Read More
The regional government of Galicia against the preparation of illegal magistral formulas
Judgment of the High Court of Justice of Galicia of 8 May 2019
Capsulas Nº 202
Background This judgment refers to a sanctioning proceeding against a healthcare center located in Galicia (a Spanish autonomous region) initiated by the Department of Health of such region. The healthcare center was charged with the commission of a serious infringement under the Spanish Legislative Decree 1/2015 consisting on the prescription and preparation of magistral formulas... Read More
The Ministry of Health updates the Guidelines for the advertising of medicinal products directed to the general public
Second edition of the “Guidelines for the advertising of medicinal products for human use directed to the general public" of the Ministry of Health, Consumption and Social Welfare
Capsulas Nº 202
In June, the Ministry of Health published the second edition of the “Guidelines for the advertising of medicinal products for human use directed to the general public”. For the drafting of this updated version of the Guidelines, the Ministry of Health has benefited from the collaboration of Autocontrol and Anefp, two Spanish associations for self-regulation... Read More
The direct action of the operating carrier against the companies preceding it in the subcontracting chain
Judgment of the Supreme Court of 6 May 2019
Capsulas Nº 202
Background On 24 November 2017, the Supreme Court ruled for the first time on how to interpret the direct action foreseen in Spanish Law 9/2013 that any operating carrier has against all companies preceding it in the subcontracting chain (that is, the company initially hiring the transport services and, when applicable, intermediate carriers). At that... Read More
Transparencia y seguridad jurídica
El Global
Últimamente se ha venido levantado cierto revuelo en torno a la consulta que ha formulado el CGCOF a la Aemps, en torno a la legalidad del uso de la aplicación WhatsApp por parte de las oficinas de farmacia como herramienta para la venta a distancia, a través de procedimientos telemáticos, de los medicamentos que no... Read More
Faus & Moliner, recognized as the best Life Sciences Law Firm at the Fourth Edition of the Awards granted by Expansión Jurídico
The award ceremony was held on 27 June during a dinner at Complejo Duques de Pastrana
Faus & Moliner has been recognized as the best Law Firm in life sciences in Spain at the Fourth Edition of the Awards granted by Expansión Jurídico, an award that recognizes the work for providing legal advice to companies and entities that operate in the healthcare sector. The finalists in this category were Baker McKenzie,... Read More
Faus & Moliner participates at the 110th Lunch Talk of the Global Competition Law Centre of the College of Europe
Jordi Faus delivers a presentation on the definition of the relevant product market in pharma competition law dossiers in light of the Servier case
The 110th launch talk of the Global Competition Law Centre (GCLC) of the College of Europe was held in Brussels on 27 June. Jordi Faus was invited to talk about the definition of relevant product market in pharma competition law dossiers, a hot topic after the General Court decided to revoke the part of the... Read More
Compra pública innovadora
El Global
La compra pública innovadora está cogiendo fuerza entre las distintas administraciones públicas sanitarias como medio para contratar la gestión de servicios de la salud. A modo de ejemplo, Cataluña ha destinado 30 millones para financiar proyectos innovadores de salud con los que dar soluciones a los nuevos retos de gestión sanitaria que plantean los cambios... Read More
El Ministerio actualiza sus directrices sobre publicidad de medicamentos dirigida al público
El Global
En los tiempos que corren todo cambia a un ritmo cada vez más vertiginoso. Las nuevas tecnologías y el progreso del mundo digital han favorecido la aparición y uso masivo de nuevos soportes publicitarios que hacen que las reglas que regulan la publicidad deban adecuarse a esta nueva realidad, y la publicidad sobre medicamentos dirigida... Read More